Literature DB >> 5786762

Nephrotic syndrome cured by removal of gastric carcinoma.

E G Cantrell.   

Abstract

Entities:  

Mesh：

Year:  1969        PMID： 5786762      PMCID： PMC1983541          DOI： 10.1136/bmj.2.5659.739

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  12 in total

1.  ASSOCIATION OF NEPHROTIC SYNDROME AND NEPHROBLASTOMA IN SIBLINGS.

Authors:  C ZUNIN; F SOAVE
Journal:  Ann Paediatr       Date:  1964

2.  [PROTEINURIA ASSOCIATED WITH PARANEOPLASTIC MANIFESTATIONS IN THE COURSE OF BRONCHIAL CANCER].

Authors:  L REVOL; J J VIALA; J P REVILLARD; Y MANUEL
Journal:  Lyon Med       Date:  1964-11-01

Review 3.  A REVIEW OF UNUSUAL SYSTEMIC MANIFESTATIONS ASSOCIATED WITH CARCINOMA.

Authors:  E GREENBERG; M B DIVERTIE; L B WOOLNER
Journal:  Am J Med       Date:  1964-01       Impact factor: 4.965

Review 4.  ORIGINS OF NEPHROTIC SYNDROMES.

Authors:  T S DANOWSKI; J V BONESSI; F A WEIGAND; F M MATEER
Journal:  Biochem Clin       Date:  1963

5.  Amyloid disease of the kidney and renal vein thrombosis.

Authors:  G P BARCLAY; H M CAMERON; L W LOUGHRIDGE
Journal:  Q J Med       Date:  1960-01

6.  Amyloidosis in association with neoplastic disease. Report of an unusual case and clinicopathological experience at Memorial Center for Cancer and Allied Diseases during eleven years (1948-1958).

Authors:  K G KIMBALL
Journal:  Ann Intern Med       Date:  1961-12       Impact factor: 25.391

7.  Clinical aspects of renal vein thrombosis.

Authors:  C V HARRISON; M D MILNE; R E STEINER
Journal:  Q J Med       Date:  1956-07

8.  Treatment of nephrotic syndrome with cation-exchange resins and high-protein low-sodium diet.

Authors:  M L ROSENHEIM; A G SPENCER
Journal:  Lancet       Date:  1956-08-18       Impact factor: 79.321

9.  Possible immunological factors in human malignant melanoma in Uganda.

Authors:  M G Lewis
Journal:  Lancet       Date:  1967-10-28       Impact factor: 79.321

10.  [Apparently primary nephrotic syndrome associated with a malignant corticosuprarenoma].

Authors:  A Domart; J Hazard; J Modaï; J Gubler; D Kleinknecht; P Vuagnat
Journal:  Bull Mem Soc Med Hop Paris       Date:  1965-05-21
View more
  11 in total

1.  Chemotherapy influencing the course of nephrotic syndrome in colonic carcinoma.

Authors:  D Goldstein; R Kelly; M Ralston; R Penny; J Hayes
Journal:  Med Oncol Tumor Pharmacother       Date:  1987

2.  The role of circulating antibody in the control of metastases.

Authors:  M G Lewis
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1974

Review 3.  Bright's disease today: the pathogenesis and treatment of glomerulonephritis. 3.

Authors:  J S Cameron
Journal:  Br Med J       Date:  1972-10-28

Review 4.  Response of paraneoplastic syndromes to antineoplastic therapy.

Authors:  M Markman
Journal:  West J Med       Date:  1986-05

5.  Carcinoma of the oesophagus associated with membrano-proliferative glomerulonephritis.

Authors:  J F Walker; S O'Neil; E Campbell; O Browne; G Doyle; M Carmody; W F O'Dwyer
Journal:  Postgrad Med J       Date:  1981-09       Impact factor: 2.401

Review 6.  Paraneoplastic syndromes.

Authors:  D C Stolinsky
Journal:  West J Med       Date:  1980-03

7.  Renal deposition of soluble immune complexes in mice bearing B-16 melanoma. Characterization of complexes and relationship to tumor progress.

Authors:  P K Poskitt; T R Poskitt; J H Wallace
Journal:  J Exp Med       Date:  1974-08-01       Impact factor: 14.307

8.  Nephrotic syndrome as the marker for underlying malignancy.

Authors:  P E Stevens; D J Rainford
Journal:  J R Soc Med       Date:  1988-07       Impact factor: 18.000

9.  [New findings in the field of paraneoplastic syndromes].

Authors:  C Laroche; A Boissonnas; J R Maury
Journal:  J R Coll Physicians Lond       Date:  1979-07

10.  Remission of nephrotic syndrome after surgical intervention for bronchogenic carcinoma: the 10-year follow-up of a patient with membranous nephropathy.

Authors:  Izumi Nagayama; Tetsu Akimoto; Yuko Ono; Yoshihiko Ueda; Daisuke Nagata
Journal:  Int Med Case Rep J       Date:  2018-07-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.